4782
cardiology is a world ارتباط مستقیم با ادمین علمی : @cardiogroup ارتباط مستقیم با مسئول روابط عمومی : @chairman1
@cardiology_channel
Share AHA_Clinical_Update_Valvular_Heart_Disease_PowerPoint_32321.pdf
@cardiology_channel
Highlights of the first day of the 2023 ESC-congres
1- SGLT2 inhibitors are recommended as class I in HF mrEF and HFpEF (dapagliflozin and empagliflozin)
2- there is no change in the strategies of antithrombotic treatment in patients with ACS :
Aspirin + P2Y12 unhibtirs for 12 months flooded by aspirin alone for life long (class I).
3- Surgery is recommended for early Prosthetic valve endocarditis (less than 6 months) with new valve replacement and complete debridement (class IC)
4- ACS management in cancer patients:
Invasive strategy if the life expectancy >6 months
Conservative management if poor prognosis
Antithrombotic therapy according to platelet count
5- SGLT2 inhibitors are recommended as first line treatment ( class I) in type 2 diabetic patients with established ASCVD (to reduce CV risk independent of glucose control , in type2 diabetic patients with HF(to reduce HF hospitalizations ), and in type 2 diabetic patients with CKD (to reduce CV risk and kidney failure risk).
6- Colchicine is the first anti-inflammatory agent (0.5 mg once daily) approved by US FDA and health Canada to reduced the risk of atherothrombotic events in patients with established ASCVD.
7-Colchicine does not significantly reduce perioperative Afib or myocardial injury after non-cardiac surgery (MINS) in patients undergoing major non-cardiac thoracic surgery.
8- Semaglutide (which belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists) improves heart failure-related symptoms and physical function and results in greater weight loss compared with placebo in patients with HFpEF and obesity (STEP-HFpEF trial)
9- NOACs are finally approved for the treatment of LV thrombus as a complication of ACS( class IIa).
10- DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants
11- complete revascularization should be done either during the index procedure or within 45 days in patients with STEMI (class I).
12- face to an out-hospital cardiac arrest, Primary PCI is recommended as class I when the ECG shows ST segment elevation and class IIIA when the ECG is normal (no routine immediate coronary angiogram).
@cardiology_channel
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
@cardiology_channel
2023 ESC Guidelines for the management of endocarditis
@cardiology_channel
2023 ESC Guidelines for the management of acute coronary syndromes
@cardiology_channel
با سلام
پنجمین وبینار تخصصی
Retrograde Approach In CTO PCI
در سال ۱۴۰۲
۵ شنبه
۲ شهریور ماه
ساعت ۱۴ به صورت آنلاین برگزار میشود.
از تمامی اساتید درخواست می شود که با کلیک بر روی لینک ذیل در این جلسه شرکت نمایند.
https://www.skyroom.online/ch/jahantebdarman1/jtd
@cardiology_channel
Don’ t understimate MVP
PICKELHAUBE SIGN in a young survivor of sudden cardiac death is an echocardiographic marker associated with sudden cardiac death in myxomatous mitral valve prolapse and indicates malignant and arrhythmogenic phenotype of myxomatous mitral valve disease (MMVD) and bileaflet MVP.
It's a high-velocity systolic spike (≥ 16 cm/s) in the Tissue Doppler Velocity Signal which resemble pickel haube.
@cardiology_channel
The biggest PA aneurysm ever (exceeds 22x14 cm)
@cardiology_channel
In coronary artery disease (CAD) ,MI yeild to regional scar and loss of contractility → adverse remodeling of remaining segments → LV dilatation and dysfunction , finally results in LV systolic dysfunction
Hypertension (HTN) ,initially causes concentric LV hypertrophy (LVH) but can eventually progress to dilated cardiomyopathy and LV systolic dysfunction
Cocaine pathophysiology,as a cause of cardiomyopathy is coronary vasospasm and direct myocardial toxicity
Medications such as anthracyclines, trastuzumab, cyclophosphamide have direct myocardial toxicity
@cardiology_channel
Antithrombotic therapy in patients with severe infections
@cardiology_channel
Dosing time optimization of antihypertensive medications by including the circadian rhythm in pharmacokinetic-pharmacodynamic models
@cardiology_channel
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
@cardiology_channel
2023 ESC Guidelines for the management
of cardiomyopathies
@cardiology_channel
ACC/AHA and ESC/EACTS Guidelines for the Management of
Valvular Heart Diseases
با تشكر فراوان از استاد عزيزم جناب آقاى دكترسيدرضاميري
فوق تخصص قلب جنين-جوان
فلوشيپ اينترونشنال كارديولوژي
@cardiology_channel
Peripartum Cardiomyopathy occurs in last month of pregnancy or within 5 months of delivery.
LV function usually improves but high rate of recurrent dysfunction with subsequent pregnancies.
Endocrine causes of the cardiomyopathy :
(1) Hypothyroidism
(2) Pheochromocytoma
(3) Acromegaly
(4) Thiamine deficiency(vit B1)
@cardiology_channell
The ACC/AHA guideline recommends pharmacological treatment for hypertension in which of the following stages of chronic aortic regurgitation?
A. Stages A and B
B. Stages B and C
C. Stages C2 and D
D. Stage D
The answer is: B
In patients with severe chronic aortic regurgitation, systolic blood pressure is typically higher than in patients without aortic regurgitation. The 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease recommends that patients with asymptomatic (Stage B and Stage C) chronic aortic regurgitation receive vasodilators to treat hypertension.
@cardiolog_channel
Therapies to Reduce CV Risk in CKD and DM